Author

Xu Liu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Stevioside promotes hepatocyte proliferation via YAP signaling in cholestatic disease.

It is established that stevioside repairs cholestatic injury by directly driving region-restricted hepatocyte proliferation via YAP signaling, highlighting its potential as a mechanistically innovative candidate for the treatment of cholestatic liver diseases.

Wei Jiang, Xu Fang, Yi-Meng Sun et al. · Acta Pharmacologica Sinica · 0 citations

Open access Aug 2026

Exploring the Therapeutic Effects of Artemisia rupestris L. Extract on Metabolic Dysfunction-Associated Fatty Liver Disease: Network Pharmacology and In Vitro Experiments

This study preliminarily elucidated the beneficial effects of ARE on lipid deposition in hepatocytes and its potential mechanism, thereby providing an experimental basis and potential avenues for subsequent in vivo studies on pharmacodynamics, pharmacokinetics, and toxicology.

Zhe-Ming Xiong, Yian Su, Lu-Ping Shi et al. · Pharmaceuticals · 0 citations